Browsing: Diaspora professionals

Kenyans in the diaspora | Diaspora remittances
  • Kenya is among the top three countries receiving the most international remittances across sub-Saharan Africa, after Nigeria and Ghana. Overall, the US, Saudi Arabia and UK account for nearly three-quarters of total annual inflows into Kenya.
  • Kenyans living abroad sent home $357 million in March 2023, a 15.5 percent increase compared to February.
  • As a whole remittances from the African diaspora are estimated at $95.6 billion annually, making it a key foreign exchange earner.     

Diaspora remittances have risen to become Kenya’s largest foreign exchange earner, surpassing the country’s key exports such as tourism, tea, coffee and horticulture. According to Central Bank of Kenya (CBK) data, diaspora remittances rose by 8.34 percent to $4.027 billion in 2022. In the same period under review, tea exports earned the country $1.2 billion, horticulture $901 million, chemicals $521 million, coffee $301 million and petroleum products $77 million. The widening disparity highlights the crucial role …

A research lab. Many African governments don’t spend a significant percentage of their GDP on research. www.theexchange.africa

In most OECD countries, commercialization of research and innovation is very commonplace and is a foundation to establish national, region and global tech and industrial titans.
Where is Africa with this strategy? And, how can Africa engage and attract its diaspora professionals to scale ground breaking research innovations that can scale and solve local problems?
Furthermore, these African researchers work on projects that have the potential to impact Africa and mankind. Think about all the lifesaving medications we take every day, yes, an African researcher may have research or an innovation in Life Science that could save thousands or even millions of lives per year. In tropic Africa, we have the largest biodiversity in the world – can an enzyme from a plant with the help from the latest Artificial Intelligence, come up with the next billion-dollar drug? …